Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Oct;34(10):2475–2478. doi: 10.1128/jcm.34.10.2475-2478.1996

Monoclonal infection involving Mycobacterium avium presenting with three distinct colony morphotypes.

E L Wright 1, S Zywno-van Ginkel 1, N Rastogi 1, W W Barrow 1
PMCID: PMC229297  PMID: 8880503

Abstract

Recent reports indicate that polyclonal infections may play an important role in multiple drug resistance in Mycobacterium avium infections. We report here on the isolation of a single M. avium strain that appeared to have smooth colony morphology upon initial isolation on a Lowenstein-Jensen slant. Primary subculture onto Middlebrook 7H10, however, revealed three distinct morphotypes representing smooth opaque (SmO), smooth transparent (SmT), and rough (Rg) colony morphologies. All three morphotypes were identified as M. avium by standard biochemical procedures, Genprobe analysis, and mycolic acid patterns. Subsequent restriction fragment length polymorphism analysis, using SalI- and PvuII-digested genomic DNA, revealed identical patterns for hybridization with the IS1245 probe. Thin-layer chromatographic analysis of lipids from the three morphotypes revealed that only the SmT morphotype possessed what appeared to be lipid components similar to, but unlike, previously described serovar-specific glycopeptidolipid antigens. Further analysis of internally radiolabeled deacylated lipids from the SmT morphotype, by high-performance liquid chromatography and thin-layer chromatography, disclosed that some of these components can be internally radiolabeled with [14C] phenylalanine and [14C]mannose. These results suggest that these components are structurally similar to previously described glycopeptidolipid antigens. This is apparently the first report of a monoclonal infection involving a single strain of M. avium presenting with all three colony morphotypes, SmO, SmT, and Rg.

Full Text

The Full Text of this article is available as a PDF (183.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbeit R. D., Slutsky A., Barber T. W., Maslow J. N., Niemczyk S., Falkinham J. O., 3rd, O'Connor G. T., von Reyn C. F. Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J Infect Dis. 1993 Jun;167(6):1384–1390. doi: 10.1093/infdis/167.6.1384. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. F., Le H. Q., Davidson P. T. Tuberculosis in patients with HIV infection. Med Clin North Am. 1993 Nov;77(6):1369–1390. doi: 10.1016/s0025-7125(16)30199-7. [DOI] [PubMed] [Google Scholar]
  3. Barrow W. W., Brennan P. J. Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens. J Bacteriol. 1982 Apr;150(1):381–384. doi: 10.1128/jb.150.1.381-384.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barrow W. W., Davis T. L., Wright E. L., Labrousse V., Bachelet M., Rastogi N. Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8. Infect Immun. 1995 Jan;63(1):126–133. doi: 10.1128/iai.63.1.126-133.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barrow W. W., Wright E. L., Goh K. S., Rastogi N. Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium. Antimicrob Agents Chemother. 1993 Apr;37(4):652–661. doi: 10.1128/aac.37.4.652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. David H. L. Basis for lack of drug susceptibility of atypical mycobacteria. Rev Infect Dis. 1981 Sep-Oct;3(5):878–884. doi: 10.1093/clinids/3.5.878. [DOI] [PubMed] [Google Scholar]
  7. Ellner J. J., Goldberger M. J., Parenti D. M. Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J Infect Dis. 1991 Jun;163(6):1326–1335. doi: 10.1093/infdis/163.6.1326. [DOI] [PubMed] [Google Scholar]
  8. FREGNAN G. B., SMITH D. W. Description of various colony forms of mycobacteria. J Bacteriol. 1962 Apr;83:819–827. doi: 10.1128/jb.83.4.819-827.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Guerrero C., Bernasconi C., Burki D., Bodmer T., Telenti A. A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness. J Clin Microbiol. 1995 Feb;33(2):304–307. doi: 10.1128/jcm.33.2.304-307.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rastogi N., Goh K. S., Van Ginkel S. Z., Wright E. L., Barrow W. W. Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis. Res Microbiol. 1996 Jan-Feb;147(1-2):97–105. doi: 10.1016/0923-2508(96)80210-5. [DOI] [PubMed] [Google Scholar]
  11. Rastogi N., Goh K. S., Wright E. L., Barrow W. W. Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques. Antimicrob Agents Chemother. 1994 Oct;38(10):2287–2295. doi: 10.1128/aac.38.10.2287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Slutsky A. M., Arbeit R. D., Barber T. W., Rich J., von Reyn C. F., Pieciak W., Barlow M. A., Maslow J. N. Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates. J Clin Microbiol. 1994 Jul;32(7):1773–1778. doi: 10.1128/jcm.32.7.1773-1778.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Structure and functions of the cell envelope in relation to mycobacterial virulence, pathogenicity and multiple drug resistance. 7th Forum in Microbiology. Res Microbiol. 1991 May;142(4):419–481. doi: 10.1016/0923-2508(91)90112-n. [DOI] [PubMed] [Google Scholar]
  14. Wright E. L., Barrow W. W. Inhibition of glycopeptidolipid synthesis resulting from treatment of Mycobacterium avium with 2-deoxy-D-glucose. Res Microbiol. 1991 Jun;142(5):597–608. doi: 10.1016/0923-2508(91)90193-e. [DOI] [PubMed] [Google Scholar]
  15. von Reyn C. F., Jacobs N. J., Arbeit R. D., Maslow J. N., Niemczyk S. Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient. J Clin Microbiol. 1995 Apr;33(4):1008–1010. doi: 10.1128/jcm.33.4.1008-1010.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. von Reyn C. F., Pestel M., Arbeit R. D. Clinical and epidemiologic implications of polyclonal infection due to Mycobacterium avium complex. Res Microbiol. 1996 Jan-Feb;147(1-2):24–30. doi: 10.1016/0923-2508(96)80199-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES